Res 2024-047 approving a contract with Cenikor to provide a

Home Browse Search

DocuSign Envelope ID:COA2C376-DO83-4406-8D6C-OA6C2103A7F3 Submitted 3/15/24 �� uu�, uuumuiu IV �'"i�llll�i(�N�ooiu�i��\'"I uui��1 uuuumu nod uuuuuuu III!I!I111....111...1110III!.!..Ito III4 IE) II�'.III!Ir!�'m �III!li Illy Cenikor Proposal for Utilization of Opioid Funds in Collaboration with the City of San Marcos Program Summary The proposal aims to implement comprehensive strategies to address opioid-related misuse and use within the San Marcos community. By integrating Medicated Assistant Treatment (MAT), prevention education, and harm reduction approaches, the initiative seeks to leverage evidence- based practices to mitigate the impacts of opioid misuse. The core objective is to foster a healthier, safer community through targeted interventions and educational programs. Beneficiaries The primary beneficiaries of this program will be members of the San Marcos community, encompassing individuals directly or indirectly affected by opioid misuse or addiction. Timeline: Program Services April 2024 to April 2025, with the possibility of extension based on additional fund allocations. Budget and Staffing: There will be a need for a Contract Nurse Practitioner to administer MAT induction assessments, follow-up maintenance, and medication orders. The budget would include this Contract Nurse Practitioner position to monitor and document on clients served for MAT services. An additional part-time team member up to 28 hours per week, 4 days a week, will be hired to document and support the full scope of services for this overall program. Other expenses for this program would include the training, travel, supplies, occupancy costs, and indirect overhead. The program would be managed by the Director of Ancillary Services. Activities and Performance Measures 1. Monitoring the number of residents benefiting from Medication-Assisted Treatment (MAT): Measure the quarterly increase or decrease in residents enrolled in MAT program,tracking progress over a monthly time period to evaluate the program's expansion or contraction. 2. Tracking the engagement of healthcare providers in Annual opioid prescription training: Annually quantify the number of healthcare providers who complete opioid prescription training, assessing year-over-year trends to gauge increased provider engagement and training uptake; this can be tracked via the sign-in and enrollment forms. 3. Reporting on the reach and impact of Naloxone training sessions: Document the number of training sessions conducted quarterly and the total number of participants, alongside pre-and post- assessment scores to evaluate knowledge gained and the program's immediate impact. Scores can be subjected to a survey provided. 4. Documenting the scope of fentanyl education initiatives: Record the number of fentanyl education presentations given quarterly and the audience size, coupled with feedback surveys to assess information retention and changes in audience perceptions.